4.7 Article

Sequentially releasing self-healing hydrogel fabricated with TGFβ3-microspheres and bFGF to facilitate rat alveolar bone defect repair

Journal

ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 17, Issue 3, Pages 425-434

Publisher

SHENYANG PHARMACEUTICAL UNIV
DOI: 10.1016/j.ajps.2022.03.003

Keywords

Self-healing hydrogel; TGF beta 3 microspheres; bFGF; Sequential release; Alveolar defects

Funding

  1. Guangzhou Science and Technology Program Key Project [201803010044]
  2. Guangdong Province College Characteristic Innovation Project [2019KTSCX011]
  3. Guangdong Province Natural Sciences Fund Project [2021A1515012480]
  4. Key Areas Research and Development Program of Guangzhou [202103030003]
  5. Guangdong Province Special Fund Projects (Yueziranzihe,2021) [50]

Ask authors/readers for more resources

Resorption and loss of alveolar bone can lead to oral dysfunction and tooth loss. Biomimetic delivery of growth factors based on stem cell recruitment and osteogenic differentiation has been a popular research area for alveolar bone regeneration. A self-healing hydrogel was developed, which can promote blood vessel formation, recruit stem cells, and facilitate bone tissue formation. The optimized formulation showed accelerated bone regeneration in an alveolar defect model. This research is of great significance for alveolar bone regeneration.
Resorption and loss of alveolar bone leads to oral dysfunction and loss of natural or implant teeth. Biomimetic delivery of growth factors based on stem cell recruitment and osteogenic differentiation, as the key steps in natural alveolar bone regenerative process, has been an area of intense research in recent years. A mesoporous self-healing hydrogel (DFH) with basic fibroblast growth factor (bFGF) entrapment and transforming growth factor beta 3 (TGF beta 3) - loaded chitosan microspheres (CMs) was developed. The formulation was optimized by multiple tests of self-healing, in-bottle inversion, SEM, rheological, swelling rate and in vitro degradation. In vitro tubule formation assays, cell migration assays, and osteogenic differentiation assays confirmed the ability of DFH to promote blood vessels, recruit stem cells, and promote osteogenic differentiation. The optimum DFH formula is 0.05 ml 4Arm-PEG-DF (20%) added to 1 ml CsGlu (2%) containing bFGF (80 ng) and TGF beta 3-microspheres (5 mg). The results of in vitro release studied by Elisa kit, indicated an 95% release of bFGF in 7 d and long-term sustained release of TGF beta 3. For alveolar defects rat models, the expression levels of CD29 and CD45, the bone volume fraction, trabecular number, and trabecular thickness of new bone monitored by Micro-CT in DFH treatment groups were significantly higher than others (*P < 0.05, vs Model). HE and Masson staining show the same results. In conclusion, DFH is a design of bionic alveolar remodelling microenvironment, that is in early time microvessels formed by bFGF provide nutritious to recruited endogenous stem cells, then TGF beta 3 slowly released speed up the process of new bones formation to common facilitate rat alveolar defect repair. The DFH with higher regenerative efficiency dovetails nicely with great demand due to the requirement of complicated biological processes. (C) 2022 Shenyang Pharmaceutical University. Published by Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available